BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 33067622)

  • 21. Erdheim-Chester Disease: a Rare but Important Cause of Recurrent Pericarditis.
    Chahine J; Alzubi J; Alnajjar H; Ramchand J; Chetrit M; Klein AL
    Curr Cardiol Rep; 2020 Jun; 22(8):75. PubMed ID: 32607694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome.
    Sano S; Oshima K; Wang Y; MacLauchlan S; Katanasaka Y; Sano M; Zuriaga MA; Yoshiyama M; Goukassian D; Cooper MA; Fuster JJ; Walsh K
    J Am Coll Cardiol; 2018 Feb; 71(8):875-886. PubMed ID: 29471939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profound systemic alteration of the immune phenotype and an immunoglobulin switch in Erdheim-Chester disease in 78 patients from a single center.
    Aubart FC; Poupel L; Saint-Charles F; Charlotte F; Arsafi Y; Frisdal E; Roos-Weil D; Emile JF; Amoura Z; Guerin M; Lesnik P; Haroche J; Le Goff W
    Haematologica; 2022 Jun; 107(6):1347-1357. PubMed ID: 34647443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abdominal involvement in Erdheim-Chester disease (ECD): MRI and CT imaging findings and their association with BRAF
    Nikpanah M; Kim L; Mirmomen SM; Symons R; Papageorgiou I; Gahl WA; O'Brien K; Estrada-Veras JI; Malayeri AA
    Eur Radiol; 2018 Sep; 28(9):3751-3759. PubMed ID: 29556768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histiocytic disorders: insights into novel biology and implications for therapy of Langerhans cell histiocytosis and Erdheim-Chester disease.
    McClain K
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):395-399. PubMed ID: 33275721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease.
    Cobo I; Tanaka T; Glass CK; Yeang C
    Curr Opin Hematol; 2022 Jan; 29(1):1-7. PubMed ID: 34654019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case report of a patient with Erdheim-Chester disease presenting with neuro-endocrine symptoms and negative for BRAF mutation.
    Lu L; Zhou J; Yan X; Jin R; Deng S; Lu W; Chen D
    Medicine (Baltimore); 2023 May; 102(20):e33846. PubMed ID: 37335698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erdheim-Chester Disease Successfully Treated with Front-Line Single-Agent Dabrafenib.
    Salama H; Fahed Alzayed M; Alharbi KG; Khattak Z; Omer MH; Tahir L; ALhejazi A
    Am J Case Rep; 2022 Feb; 23():e935090. PubMed ID: 35171900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural history of clonal haematopoiesis seen in real-world haematology settings.
    Patel SA; Gerber WK; Zheng R; Khanna S; Hutchinson L; Abel GA; Cerny J; DaSilva BA; Zhang TY; Ramanathan M; Khedr S; Selove W; Woda B; Miron PM; Higgins AW; Gerber JM
    Br J Haematol; 2024 May; 204(5):1844-1855. PubMed ID: 38522849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
    Pascual-Figal DA; Bayes-Genis A; Díez-Díez M; Hernández-Vicente Á; Vázquez-Andrés D; de la Barrera J; Vazquez E; Quintas A; Zuriaga MA; Asensio-López MC; Dopazo A; Sánchez-Cabo F; Fuster JJ
    J Am Coll Cardiol; 2021 Apr; 77(14):1747-1759. PubMed ID: 33832602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors of Erdheim-Chester disease: a nationwide survey in Japan.
    Toya T; Ogura M; Toyama K; Yoshimi A; Shinozaki-Ushiku A; Honda A; Honda K; Hosoya N; Murakami Y; Kawashima H; Nannya Y; Arai S; Nakamura F; Shinoda Y; Nangaku M; Miyagawa K; Fukayama M; Moriya-Saito A; Katayama I; Ogura T; Kurokawa M
    Haematologica; 2018 Nov; 103(11):1815-1824. PubMed ID: 29976744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation.
    Kemps PG; Hebeda KM; Pals ST; Verdijk RM; Lam KH; Bruggink AH; de Lil HS; Ruiterkamp B; de Heer K; van Laar JA; Valk PJ; Mutsaers P; Levin MD; Hogendoorn PC; van Halteren AG
    J Pathol Clin Res; 2021 Jan; 7(1):10-26. PubMed ID: 32852896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erdheim-Chester disease.
    Campochiaro C; Tomelleri A; Cavalli G; Berti A; Dagna L
    Eur J Intern Med; 2015 May; 26(4):223-9. PubMed ID: 25865950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure.
    Yu B; Roberts MB; Raffield LM; Zekavat SM; Nguyen NQH; Biggs ML; Brown MR; Griffin G; Desai P; Correa A; Morrison AC; Shah AM; Niroula A; Uddin MM; Honigberg MC; Ebert BL; Psaty BM; Whitsel EA; Manson JE; Kooperberg C; Bick AG; Ballantyne CM; Reiner AP; Natarajan P; Eaton CB;
    J Am Coll Cardiol; 2021 Jul; 78(1):42-52. PubMed ID: 34210413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TET2 mutation as prototypic clonal hematopoiesis lesion.
    Guarnera L; Jha BK
    Semin Hematol; 2024 Feb; 61(1):51-60. PubMed ID: 38431463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.
    Genovese G; Kähler AK; Handsaker RE; Lindberg J; Rose SA; Bakhoum SF; Chambert K; Mick E; Neale BM; Fromer M; Purcell SM; Svantesson O; Landén M; Höglund M; Lehmann S; Gabriel SB; Moran JL; Lander ES; Sullivan PF; Sklar P; Grönberg H; Hultman CM; McCarroll SA
    N Engl J Med; 2014 Dec; 371(26):2477-87. PubMed ID: 25426838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effective High-dose Interferon-α Therapy in a 13-Year-Old Girl With Erdheim-Chester Disease.
    Tezol O; Citak EC; Ayhan YS; Balci Y; Koc ZP; Yuyucu Karabulut Y
    J Pediatr Hematol Oncol; 2020 May; 42(4):326-331. PubMed ID: 31259822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene rearrangements in bone marrow cells of patients with acute myelogenous leukemia.
    Schmetzer HM; Braun S; Wiesner D; Duell T; Gerhartz HH; Mittermueller J
    Acta Haematol; 2000; 103(3):125-34. PubMed ID: 10940650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erdheim-Chester disease: a comprehensive review from the ophthalmologic perspective.
    Kanakis M; Petrou P; Lourida G; Georgalas I
    Surv Ophthalmol; 2022; 67(2):388-410. PubMed ID: 34081930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation.
    Hervier B; Haroche J; Arnaud L; Charlotte F; Donadieu J; Néel A; Lifermann F; Villabona C; Graffin B; Hermine O; Rigolet A; Roubille C; Hachulla E; Carmoi T; Bézier M; Meignin V; Conrad M; Marie L; Kostrzewa E; Michot JM; Barete S; Taly V; Cury K; Emile JF; Amoura Z;
    Blood; 2014 Aug; 124(7):1119-26. PubMed ID: 24894769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.